Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective response

Abstract Purpose Chemoradiotherapy (CHRT) yields a favorable antitumor activity in patients with limited-stage small-cell lung cancer (LD-SCLC) with a response rate of around 80%. Even in such responders, the majority recur, indicating the importance of identifying a subset of patients with a poor o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Lung cancer (Amsterdam, Netherlands) Netherlands), 2012-10, Vol.78 (1), p.107-111
Hauptverfasser:	Fujii, Masanori, Hotta, Katsuyuki, Takigawa, Nagio, Hisamoto, Akiko, Ichihara, Eiki, Tabata, Masahiro, Tanimoto, Mitsune, Kiura, Katsuyuki
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences Chemoradiotherapy Disease Progression Early response Female Hematology, Oncology and Palliative Medicine Humans Limited-disease small-cell lung cancer Lung Neoplasms - mortality Lung Neoplasms - pathology Lung Neoplasms - therapy Male Medical sciences Middle Aged Neoplasm Staging Pneumology Prognosis Pulmonary/Respiratory Retrospective Studies Small Cell Lung Carcinoma - mortality Small Cell Lung Carcinoma - pathology Small Cell Lung Carcinoma - therapy Treatment Outcome Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!